|Salary:||From £40,125 per annum, subject to skills and experience|
|Placed On:||9th February 2023|
|Closes:||2nd March 2023|
Location: The Francis Crick Institute, Midland Road, London
An exciting opportunity to be part of a new collaboration between the Crick Chemical Biology Science and Technology Platform and the laboratories of Dr. Louise Walport and Prof. Ed Tate, based jointly at the Crick and Imperial College London, and working closely with Prof. Mike Waring at the University of Newcastle
We are seeking a motivated and enthusiastic synthetic chemist or chemical biologist to lead a project involving design, synthesis and screening of new small molecule DELs, hit validation and further characterisation of mode of action. The successful candidate will be responsible for leading and conducting their own research as part of a small team, working closely with other members of the Chemical Biology STP and the Walport and Tate groups. Your work will involve application of a wide range of techniques in synthetic chemistry, drug discovery, chemical biology, protein biochemistry and biophysics. We are therefore seeking someone with experience in a selection of these approaches and a willingness to learn others, as dictated by the project.
The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.
An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London.
The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under in one building in Europe.
The Francis Crick Institute will be world-class with a strong national role. Its distinctive vision for excellence includes commitments to collaboration; developing emerging talent and exporting it the rest of the UK; public engagement; and helping turn discoveries into treatments as quickly as possible to improve lives and strengthen the economy.
Type / Role: